Madisch A, Heydenreich CJ, Wieland V et al.:Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter ...

In addition, patients with functional heartburn should demonstrate lack of response to a full course of PPI treatment. Functional dyspepsia is defined by the Rome III Committee for Functional ...

No drugs, including proton pump inhibitors, are approved for treatment of the FD symptoms in Japan. Gastric mucosa-protecting agents are frequently used to treat dyspepsia that causes heaviness or ...

Functional dyspepsia is a common digestive disorder, with more than one in ten Koreans suffering. Some of these patients wander from one hospital to another, searching for a precise cause and ...

The open label design of the study might have increased the expectations for the treatment effect both by patients and doctors, though this effect should have occurred equally for both medications.

At weeks 10, 11 and 12 the percentage of individuals with clinically significant heartburn, dyspepsia or acid regurgitation ... returned to baseline after treatment was stopped.

Welcome to this page which serves as an archive for medications that are relevant to the treatment of Indigestion. The page includes both the generic and brand names and can serve as an invaluable ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of ...

One of the stranger legends surrounding the controversial Confederate general Stonewall Jackson is the fact that Jackson's ...

Considering taking supplements to treat dyspepsia? Below is a list of common natural remedies used to treat or reduce the symptoms of dyspepsia. Follow the links to read common uses, side effects ...

For informational purposes only. Consult a medical professional for advice. Source: Focus Medica. A condition where digestion is impaired. It causes persistent or recurrent pain or discomfort in ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...